Skip to main content

Bradley Quon

Associate Professor


Dr. Quon is a clinician-scientist with advanced training in biomarker research, epidemiology, and clinical respirology/cystic fibrosis. Dr. Quon received his BSc at the University of British Columbia (UBC) in Microbiology and Immunology. He completed the combined MD/MBA program at McGill University. Subsequently, he completed residency training in Internal Medicine and fellowship training in Respirology at UBC. Following completion of clinical training, he undertook two years of formal clinical research training in cystic fibrosis at the University of Washington. He is currently Associate Professor of Medicine and Principal Investigator at the University of British Columbia Centre for Heart Lung Innovation. He holds a Michael Smith Foundation for Health Research Scholar Award and is currently the Medical Lead of the CF Canada Clinical Trial Network.

Education & Training

  • BSc Microbiology and Immunology – University of British Columbia
  • MD – Mcgill University
  • MBA – McGill University
  • MSc, Epidemiology and Biostatistics – University of Washington

Area of Interest

My research program is dedicated to developing better tools to diagnose and monitor conditions that complicate the lives of individuals living with cystic fibrosis (CF) including pulmonary exacerbations, allergic bronchopulmonary aspergillosis, and non-tuberculous mycobacteria. We use innovative tools including proteomics and transcriptomics to characterize blood and sputum samples at a molecular level and apply computational and systems biology methods to improve our understanding of these conditions. The ultimate goal is to develop biomarkers that can be used by CF clinicians in the future to improve the clinical care of these conditions. Another major interest of my research program is to understand the burden of CF on our patients and the health care system. We use administrative and registry-based data sets to examine CF health outcomes and how this may vary based on stage of the patient’s disease and access to treatment.

Team Members

  • Jiah Jang – Research technician
  • Kang Dong PhD student, Experimental Medicine
  • Sameer Desai – PhD student, School of Population and Public Health
  • Miguel Prieto – MSc student, Experimental Medicine
  • Naomi Potter – MSc student, Experimental Medicine